Literature DB >> 24424368

Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.

Yeon-Ah Sung1, Jee-Young Oh1, Hyewon Chung2, Hyejin Lee3.   

Abstract

OBJECTIVE: To determine the features of polycystic ovary syndrome (PCOS) that are implicated in the associated reproductive and metabolic morbidities.
DESIGN: Cross-sectional case-control study.
SETTING: Academic medical setting. PATIENT(S): A total of 1,062 women with PCOS and 1,887 women without PCOS. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Physical examination including hirsutism scoring, biochemical and hormone measurements, ovarian ultrasound, and a 75-g oral glucose tolerance test to measure glucose and insulin levels. RESULT(S): A factor analysis identified four dominant factors in women with PCOS. These factors were interpreted as follows: [1] metabolic and hyperandrogenemia factor, [2] oligomenorrhea and hyperandrogenemia factor, [3] blood pressure factor, and [4] ovarian morphology factor. In women with PCOS, hyperandrogenemia was a significant predictor of metabolic syndrome after adjusting for age, body mass index, and insulin resistance in the regression analysis. CONCLUSION(S): A factor analysis identified multiple factors that are responsible for the abnormalities associated with PCOS. Hyperandrogenemia was a common underlying feature of the metabolic and reproductive abnormalities in women with PCOS but not in women without PCOS.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperandrogenemia; metabolic morbidity; polycystic ovary syndrome; reproductive morbidity

Mesh:

Substances:

Year:  2014        PMID: 24424368     DOI: 10.1016/j.fertnstert.2013.11.027

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

1.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

2.  Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study.

Authors:  Zhenteng Liu; Cuifang Hao; Dehua Song; Ning Zhang; Hongchu Bao; Qinglan Qu
Journal:  Reprod Sci       Date:  2014-12-31       Impact factor: 3.060

Review 3.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

4.  Sonographic markers of ovarian morphology, but not hirsutism indices, predict serum total testosterone in women with regular menstrual cycles.

Authors:  Heidi Vanden Brink; Amy D Willis; Brittany Y Jarrett; Annie W Lin; Steven Soler; Siân Best; Erica L Bender; Andrew K Peppin; Kathleen M Hoeger; Marla E Lujan
Journal:  Fertil Steril       Date:  2016-01-27       Impact factor: 7.329

5.  Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.

Authors:  Roberto Mioni; Anna Dalla Cà; Jenni Turra; Sara Azzolini; Nadia Xamin; Luigi Bleve; Pietro Maffei; Roberto Vettor; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-03       Impact factor: 3.633

6.  A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances.

Authors:  F Ramezani Tehrani; S Behboudi-Gandevani; M Simbar; F Azizi
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

Review 7.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

8.  Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.

Authors:  Narges Zaeemzadeh; Shahideh Jahanian Sadatmahalleh; Saeideh Ziaei; Anoshirvan Kazemnejad; Azadeh Mottaghi; Neda Mohamadzadeh; Maryam Movahedinejad
Journal:  Int J Reprod Biomed       Date:  2020-04-30

9.  Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography.

Authors:  José Edvan de Souza-Júnior; Carlos Alexandre de Amorim Garcia; Elvira Maria Mafaldo Soares; Técia Maria Oliveira Maranhão; Telma Maria Araújo Moura Lemos; George Dantas Azevedo
Journal:  J Ophthalmol       Date:  2015-02-11       Impact factor: 1.909

Review 10.  Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis.

Authors:  Rui Yang; Shuo Yang; Rong Li; Ping Liu; Jie Qiao; Yanwu Zhang
Journal:  Reprod Biol Endocrinol       Date:  2016-10-18       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.